Gadolinium in human brain sections and colocalization with other elements

Ahmed H El-Khatib¹, Helena Radbruch¹, Sabrina Trog¹+6

• ¹Department of Chemistry (A.H.E.-K., S.T., M.W.L.), Humboldt-Universität zu Berlin, Germany; Pharmaceutical Analytical Chemistry Department (A.H.E.-K.), Faculty of pharmacy, Ain Shams University, Cairo, Egypt; Bundesanstalt für Materialforschung und -prüfung (BAM) (A.H.E.-K., N.J.), Berlin, Germany; Department of Neuropathology (H.R., A.K.), Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health; Proteome Factory AG (B.N.), Berlin, Germany; Institute of Pharmacology (B.N.), Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health; NeuroCure Clinical Research Unit Charité-Universitätsmedizin Berlin (F.P.), Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health; Clinical and Experimental Multiple Sclerosis Research Center (F.P.), Department of Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health; and Department of Radiology (E.S.), Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.